Department of Medicine, Stavanger University Hospital, Stavanger, Norway.
Clin Chem Lab Med. 2011 Sep;49(9):1501-7. doi: 10.1515/CCLM.2011.233. Epub 2011 Jun 2.
Several articles describing within-subject biological variation of fasting glucose and HbA(1c) in healthy populations have been published, but information about biological variation of glucose and HbA(1c) in patients with type 1 diabetes is scarce. It is reasonable to assume that type 1 diabetics differ from their healthy counterparts in this matter. The aim of our study was to estimate the biological variation of glucose and HbA(1c) in healthy subjects and in patients with type 1 diabetes.
Fifteen healthy individuals and 15 type 1 diabetes patients were included. Biological variations were calculated based on blood samples collected weekly for 10 consecutive weeks from the healthy and the eligible of the type 1 diabetes patients.
The within-subject variations of glucose were approximately 5% in healthy individuals and 30% in diabetes patients, and for HbA(1c) they were 1.2% in healthy individuals and 1.7% in diabetes patients.
In conclusion, we found a high within-subject biological variation of glucose in diabetes patients as expected compared to healthy individuals (30% vs. 5%). The short-term (2 months) within-subject biological variation of HbA(1c) did not differ significantly between well regulated type 1 diabetes patients and healthy individuals (1.7% vs. 1.2%).
已有多篇文章描述了健康人群空腹血糖和 HbA(1c)的个体内生物学变异,但关于 1 型糖尿病患者血糖和 HbA(1c)的生物学变异信息却很少。可以合理地假设 1 型糖尿病患者在这方面与他们的健康对照者不同。我们研究的目的是估计健康受试者和 1 型糖尿病患者的血糖和 HbA(1c)的生物学变异。
纳入了 15 名健康个体和 15 名 1 型糖尿病患者。从健康个体和 1 型糖尿病患者中每周采集一次连续 10 周的血样,计算个体内变异。
健康个体的血糖个体内变异约为 5%,而糖尿病患者为 30%,HbA(1c)个体内变异分别为健康个体的 1.2%和糖尿病患者的 1.7%。
总之,我们发现糖尿病患者的血糖个体内生物学变异较健康个体高(30%对 5%),这是预期的结果。经过 2 个月的短期观察,血糖控制良好的 1 型糖尿病患者与健康个体的 HbA(1c)个体内生物学变异(1.7%对 1.2%)无显著差异。